Latest Aperture Therapeutics News & Updates

See the latest news and media coverage for Aperture Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Aperture Therapeutics

Biotechnology company developing therapeutics for neurodegenerative diseases

aperturetx.com

Headquarters: San Carlos, United States
Founded year: 2022
Company type: Private company
Number of employees: 5–10
Industry: Biotechnology & Medical Research

Last updated May 7

Latest news about Aperture Therapeutics

In short: Aperture Therapeutics won the Longitude Prize on ALS Discovery Award

Company announcements

May 7 Aperture Therapeutics

Aperture Therapeutics wins Longitude Prize on ALS Discovery Award

They collaborate with Harvard and Tufts labs to use ML/AI on large ALS patient datasets for new drug targets.

May 4 Aperture Therapeutics

Aperture Therapeutics attends Target ALS Annual Meeting

They join leaders from academia, industry, and clinic in Boston May 5-7 to advance ALS efforts. They invite connections between sessions.

January 6 Aperture Therapeutics

Aperture Therapeutics advances APRTX-003 program

APRTX-003 is a first-in-class antisense oligonucleotide targeting MMP9 to suppress neurodegeneration in ALS. It overcomes limitations of small molecules and antibodies.

November 19, 2025 Aperture Therapeutics

Aperture Therapeutics announces development candidate APRTX-001

APRTX-001 is a first-in-class CD33-targeting ASO suppressing microglial-driven neuroinflammation in ALS, FTD, AD, and PD. They thank NINDS and investors.

Media coverage

April 28 BioSpace

Apertura Gene Therapy and Scientists from the Broad Institute to Share Data on TfR1 CapX™, a Novel Capsid Targeting the Central Nervous System (CNS), at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - BioSpace

"We look forward to sharing Apertura's ... CTO at Apertura and Director & Gene Therapy Program Lead at Deerfield Management. "The progress we continue to...

Never miss news about Aperture Therapeutics

Track Aperture Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Aperture Therapeutics competitors & trending companies

Browse news for competitors to Aperture Therapeutics and other trending companies.